Involvement of multidrug resistance-associated protein 2 (ABCC2/Mrp2) in biliary excretion of micafungin in rats

被引:11
|
作者
Abe, Fumie [1 ]
Ueyama, Jun [2 ]
Kimata, Akiko [2 ]
Kato, Miki [1 ]
Hayashi, Tamon [1 ]
Nadai, Masayuki [3 ]
Saito, Hiroko [1 ]
Takeyama, Naoshi [4 ]
Noguchi, Hiroshi [4 ]
Hasegawa, Takaaki [1 ]
机构
[1] Aichi Med Univ, Dept Pharm & Pharmacokinet, Sch Med, Nagakute, Aichi 4801195, Japan
[2] Nagoya Univ, Dept Med Technol, Sch Hlth Sci, Higashi Ku, Nagoya, Aichi 4618673, Japan
[3] Meijo Univ, Fac Pharmaceut Sci, Tenpaku Ku, Nagoya, Aichi 4688503, Japan
[4] Aichi Med Univ, Dept Crit Care Med, Sch Med, Nagakute, Aichi 4801195, Japan
关键词
micafungin; multidrug resistance-associated protein 2 (ABCC2/Mrp2) hepatobiliary excretion; Eisai hyperbilirubinemic rats (EHBR);
D O I
10.1016/j.lfs.2008.06.013
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The drug transporter, multidrug resistance-associated protein 2 (ABCC2/Mrp2), is known to play important roles in excretion of various drugs. In the present study, we investigated whether Mrp2 is involved in the transport of micafungin, a newly developed antifungal agent. When Sprague-Dawley rats received an intravenous injection of micafungin (1 mg/kg) in combination with cyclosporine, the cyclosporine significantly delayed the disappearance of micafungin from plasma and decreased the systemic clearance and volume of distribution at steady-state of micafungin to 54% and 65% of the corresponding control values, respectively. When Sprague-Dawley rats received a constant-rate infusion of micafungin, cyclosporine significantly decreased the steady-state biliary clearance of micafungin (similar to 80%). A significant decrease in the biliary clearance of micafungin (similar to 60%) was observed in Eisai hyperbilirubinemic rats, which have a hereditary deficiency in Mrp2. The present findings at least suggest that Mrp2 is involved mainly in the hepatobiliary excretion of micafungin in rats. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:229 / 235
页数:7
相关论文
共 50 条
  • [1] Endotoxin does not alter the pharmacokinetics of micafungin, but it impairs biliary excretion of micafungin via multidrug resistance-associated protein 2 (ABCC2/Mrp2) in rats
    Noda, Takayuki
    Abe, Fumie
    Ueyama, Jun
    Kato, Miki
    Katoh, Miki
    Nadai, Masayuki
    Saito, Hiroko
    Hasegawa, Takaaki
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (02) : 207 - 213
  • [2] Multidrug resistance-associated protein 2 (MRP2; ABCC2) is the canalicular transport protein primarily responsible for biliary excretion of fexofenadine (FEX) in mice, but not in rats
    Tian, Xianbin
    Zamek-Gliszczynski, Maciej J.
    Li, Jun
    Bridges, Arlene S.
    Brouwer, Kim L. R.
    Patel, Nita J.
    Raub, Thomas J.
    DRUG METABOLISM REVIEWS, 2006, 38 : 241 - 242
  • [3] Involvement of multidrug resistance-associated protein 2 (Abcc2) in molecular weight-dependent biliary excretion of β-lactam antibiotics
    Kato, Yukio
    Takahara, Seiko
    Kato, Sayaka
    Kubo, Yoshiyuki
    Sai, Yoshimichi
    Tamai, Ikumi
    Yabuuchi, Hikaru
    Tsuji, Akira
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (06) : 1088 - 1096
  • [4] Biliary excretion of arsenic by human HepaRG cells is stimulated by selenide and mediated by the multidrug resistance protein 2 (MRP2/ABCC2)
    Zhou, Janet R.
    Kaur, Gurnit
    Ma, Yingze
    Arutyunov, Denis
    Lu, Xiufen
    Le, X. Chris
    Leslie, Elaine M.
    BIOCHEMICAL PHARMACOLOGY, 2021, 193
  • [5] Characterization of mice lacking the multidrug resistance protein Mrp2 (Abcc2)
    Chu, XY
    Strauss, JR
    Mariano, MA
    Li, J
    Newton, DJ
    Cai, XX
    Wang, RW
    Yabut, J
    Hartley, DP
    Evans, DC
    Evers, R
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 317 (02): : 579 - 589
  • [6] Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2)
    Zimmermann, Christian
    van de Wetering, Koen
    van de Steeg, Evita
    Wagenaar, Els
    Vens, Conchita
    Schinkel, Alfred H.
    DRUG METABOLISM AND DISPOSITION, 2008, 36 (04) : 631 - 640
  • [7] The role of protein synthesis and degradation in the post-transcriptional regulation of rat multidrug resistance-associated protein 2 (Mrp2, Abcc2)
    Jones, BR
    Li, W
    Cao, J
    Hoffman, TA
    Gerk, PM
    Vore, M
    MOLECULAR PHARMACOLOGY, 2005, 68 (03) : 701 - 710
  • [8] Absolute quantification of multidrug resistance-associated protein 2 (MRP2/ABCC2) using liquid chromatography tandem mass spectrometry
    Li, Na
    Nemirovskiy, Olga V.
    Zhang, Yiqun
    Yuan, Haodan
    Mo, Jianming
    Ji, Chengjie
    Zhang, Bo
    Brayman, Timothy G.
    Lepsy, Christopher
    Heath, Timothy G.
    Lai, Yurong
    ANALYTICAL BIOCHEMISTRY, 2008, 380 (02) : 211 - 222
  • [9] Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
    Ken Ogasawara
    Shripad D. Chitnis
    Reginald Y. Gohh
    Uwe Christians
    Fatemeh Akhlaghi
    Clinical Pharmacokinetics, 2013, 52 : 751 - 762
  • [10] Multidrug Resistance-Associated Protein 2 (MRP2/ABCC2) Haplotypes Significantly Affect the Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients
    Ogasawara, Ken
    Chitnis, Shripad D.
    Gohh, Reginald Y.
    Christians, Uwe
    Akhlaghi, Fatemeh
    CLINICAL PHARMACOKINETICS, 2013, 52 (09) : 751 - 762